Triple Agonist 10mg — Verification Report

From Orbitrex Peptides · Lot 3G10526US · Tested May 2026

← Back to Orbitrex Peptides

VialTalk

Verification report

Triple Agonist 10mg

Orbitrex Peptides

Score

97.1

Grade

A+

Exceptional

Lot 3G10526US

Tested May 2026

Report ID

a4e24b86

Test

Method

Result

Status

PurityFull credit

HPLC

99.81%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentPartial

Gravimetric vs label claim · tested weight not disclosed

10 mg labeled · 11.26 mg tested

Partial

EndotoxinFull credit

USP <85> compendial

Screened

Full credit

Heavy metalsFull credit

ICP-MS

Screened

Full credit

SterilityPartial

PCR / DNA microarray

Screened

Partial

Batch conformityStrong

Three-to-four vial average

Assessed

Strong

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →